CAS: 5521-57-3; 5-Methylpyrazine-2-Carboxamide

该化合物是一种具有显著特性的合成有机化合物,具有很高的纯度和稳定性,适合各种化学应用,其独特的结构和功能组提供了多种合成机会,能够发展多种化学衍生物,该化合物在制药和农用化学研究方面的潜力也得到承认.

结构式图片

相似化合物

98006-91-8 132664-85-8 98-96-4

欧盟法规

C&L通报

上下游产品

2-methylpyrazin-5-carboxylic acid 2,5-dimethyl-pyrazine 5-methylpyrazine-2-carboxylic acid methyl ester 3-carboxamido-2-hydroxy-6-methylpyrazine 5-methylpyrazin-2-amine acipimox 2-bromo-5-methyl-pyrazine

合成工艺路线路线简述

    📜3-氯-5-甲基吡嗪-2-甲腈置于sodium Hydroxide Monohydrate,5%-Palladium/activated Carbon,氢气,双氧水,三乙胺体系中,用 甲醇,水 作为反应溶剂,20.0~100.0 °C,2.0 Mpa 条件下,反应 11.0H,反应生成 5-甲基吡嗪-2-羧酰胺
    参考文献:一种2-氨基-5-甲基吡嗪的制备方法及产品与应用
    标题:一种2-氨基-5-甲基吡嗪的制备方法及产品与应用
    摘要:本发明属于化工合成领域,涉及一种2‑氨基‑5‑甲基吡嗪的制备方法及产品与应用,包括:使2‑氨基丙二酰胺和丙酮醛反应,反应生成2‑甲基‑5‑羟基‑4吡嗪酰胺;所述2‑甲基‑5‑羟基‑4吡嗪酰胺与三氯氧磷反应,反应生成2‑甲基‑5‑氯‑4‑氰基吡嗪;所述2‑甲基‑5‑氯‑4‑氰基吡嗪进行加氢反应,反应生成2‑甲基‑4‑氰基吡嗪,水解得到2‑甲基‑4‑酰胺吡嗪;所述2‑甲基‑4‑酰胺吡嗪经霍夫曼降解,得到2‑甲基‑5‑氨基吡嗪.该方法属于全新的2‑氨基‑5‑甲基吡嗪制备方法,操作简便,收率高,成本低廉,并且适合工业化放大生产.

    海关参考信息

    专利信息


    专利号:US-2023160018-A1
    优先权日:2020-04-16
    标 题 :Crybetab2 predicts poor breast cancer outcome and sensitizes tumors to nucleolin and cdk inhibition
    发明人:MERINO VANESSA FERREIRA; POMPER MARTIN; SUKUMAR SARASWATI
    权利人:UNIV JOHNS HOPKINS
    摘要:CKYPB2 induces EMT, sternness, protein synthesis and cell cycle progression through regulation of nucleolin, con-tributing to an increase in tumor growth and metastasis. CKYPB2 can be used as a prognostic marker in African American women with TNBC. CKYPB2 can further select patients with TNBC and ER positive tumors that will likely benefit from inhibitors of ribosomal RNA synthesis, CDK4 and nucleolin.

    专利号:US-2025270214-A1
    优先权日:2022-04-22
    标 题 :Method for producing 7h-pyrrolo[2,3-d]pyrimidine-4-amine derivative
    发明人:TAKEDA DAISUKE; NONOSHITA KATSUMASA; KOBAYAKAWA Yu
    权利人:TAIHO PHARMACEUTICAL CO LTD
    摘要:The present invention provides a method for producing a compound represented by formula (I) suitable for mass synthesis as API. Provided according to one aspect of the present invention is a method for producing a compound represented by formula (I) or a salt thereof, the method including deprotecting a protecting group represented by R 1 in formula (II) under basic conditions to thereby form a compound represented by formula (I) or a salt thereof.

    专利号:US-12233062-B2
    优先权日:2018-09-26
    标 题 :Heterocyclic derivatives useful as SHP2 inhibitors
    发明人:HAN HUIFENG; GAO PANLIANG; MA CUNBO; KANG DI
    权利人:JACOBIO PHARMACEUTICALS CO LTD
    摘要:This invention provides a compound of formula I, their synthesis and their use for treating a SHP2 mediated disorder. More particularly, this invention provides a pharmaceutical composition comprising the said compound.

    专利号:MX-PA04005862-A
    优先权日:2001-12-20
    标 题 :SELECTED ANTAGONIST COMPOUNDS OF PYRIMIDINE A2B, ITS SYNTHESIS AND USE.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Sato, N., Science of Synthesis, (2004) 16, 826.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知